note20 ultra 5g. >>> welcome back biontech and pfizer moving higher today the company is announcing they could see a regulatory review a soon as october. this after johnson & johnson announced plans to launch a late stage vaccine trial with up to 60,000 participants in september. joining us now for more is former fda commissioner dr. scott gottlieb